Investors

Biostage is an evolving leader in regenerative medicine, patient-specific stem cell therapy, and tissue engineering. The company develops customized bioengineered organ implants designed to restore organ function of the esophagus, trachea and bronchus damaged by disease or trauma.

Biostage has built a dedicated internal team of materials scientists, engineers and biologists who are working with our external collaborators to bring our products to the patients who need them as quickly as possible.

Stock Information
OTCQBBSTG
Press Releases
Nov 30, 2021

Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a biotechnology company with successful "first-in-human" experience in esophageal cancer and FDA approval to commence a clinical trial...

Nov 15, 2021

Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing next-generation esophageal implants based its novel Cellframe™ and Cellspan™ technology, today...

Sep 8, 2021

Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a bioengineering company developing novel organ regeneration technology based its patented Cellframe™ and Cellspan™ technology,...

More >

Contact Us

Biostage, Inc.
84 October Hill Road
Suite 11
Holliston, Massachusetts 01746
United States

Phone: 774-233-7300
Toll Free: 855-209-3104
Fax: 774-233-7302

Investor Presentation

  Download PDF

Fact Sheet